AORT Artivion, Inc.
Artivion, Inc. (AORT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 24% planned / 76% discretionary
Largest single sale: $2.0M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 11,480 | $24.97 | $286.7K | 40,160 −22.2% of holding | |
| GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 1,493 | $26.02 | $38.8K | 51,640 −2.8% of holding | |
| GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 6,510 | $27.27 | $177.5K | 53,133 −10.9% of holding | |
| Mackin James P | President & CEO | Sell | 70,000 | $28.95 | $2.0M | 877,275 −7.4% of holding | |
| Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 715 | $28.55 | $20.4K | 210,112 −0.3% of holding | |
| GREEN ANDREW M | SVP, Regulatory and Quality | Sell | 616 | $28.55 | $17.6K | 59,643 −1% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 977 | $28.49 | $27.8K | 184,118 −0.5% of holding | |
| GREEN ANDREW M 2 fills | SVP, Regulatory and Quality | Sell 10b5-1 | 44,001 | $20.70 | $910.7K | 60,259 −42.2% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 8,962 | $38.00 | $340.6K | 185,095 −4.6% of holding | |
| Mackin James P | President & CEO | Sell | 17,887 | $37.78 | $675.7K | 947,275 −1.9% of holding | |
| Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 6,316 | $37.78 | $238.6K | 210,827 −2.9% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 4,573 | $37.78 | $172.7K | 230,794 −1.9% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 3,843 | $37.78 | $145.2K | 194,057 −1.9% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2,149 | $37.78 | $81.2K | 60,097 −3.5% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 901 | $37.78 | $34.0K | 139,088 −0.6% of holding | |
| Mackin James P | President & CEO | Sell | 14,911 | $38.02 | $567.0K | 848,214 −1.7% of holding | |
| Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 5,178 | $38.02 | $196.9K | 176,269 −2.9% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 2,784 | $38.02 | $105.9K | 206,522 −1.3% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 2,183 | $38.02 | $83.0K | 170,105 −1.3% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 1,513 | $38.02 | $57.5K | 40,408 −3.6% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 641 | $38.02 | $24.4K | 132,514 −0.5% of holding | |
| Mackin James P | President & CEO | Sell | 13,936 | $35.69 | $497.4K | 766,095 −1.8% of holding | |
| Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 4,485 | $35.69 | $160.1K | 143,965 −3% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 2,075 | $35.69 | $74.1K | 188,868 −1.1% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 1,668 | $35.69 | $59.5K | 152,203 −1.1% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 1,259 | $35.69 | $44.9K | 41,921 −2.9% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 830 | $35.69 | $29.6K | 127,497 −0.6% of holding | |
| Mackin James P | President & CEO | Sell | 20,962 | $37.59 | $787.9K | 780,031 −2.6% of holding | |
| Berry Lance A | EVP, COO, CFO & Treasurer | Sell | 4,981 | $37.59 | $187.2K | 148,450 −3.2% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 3,773 | $37.59 | $141.8K | 190,943 −1.9% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 3,079 | $37.59 | $115.7K | 153,871 −2% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2,423 | $37.59 | $91.1K | 43,180 −5.3% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 1,731 | $37.59 | $65.1K | 128,327 −1.3% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 5,000 | $45.11 | $225.6K | 193,842 −2.5% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 4,572 | $44.42 | $203.1K | 130,058 −3.4% of holding | |
| Mackin James P | President & CEO | Sell 10b5-1 | 30,921 | $45.46 | $1.4M | 800,993 −3.7% of holding | |
| Holloway Jean F 2 fills | SVP, General Counsel | Sell | 7,315 | $45.30 | $331.4K | 161,360 −4.3% of holding | |
| Mackin James P | President & CEO | Sell 10b5-1 | 30,921 | $45.56 | $1.4M | 800,993 −3.7% of holding | |
| Stanton Marshall S. 4 fills | SVP, Clinical & MD Affair | Sell | 47,376 | $45.04 | $2.1M | 53,123 −47.1% of holding | |
| Stanton Marshall S. 3 fills | SVP, Clinical & MD Affair | Sell | 15,276 | $44.18 | $674.8K | 44,753 −25.4% of holding | |
| Hoff Elizabeth A | Director | Sell | 4,200 | $45.10 | $189.4K | 27,189 −13.4% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell 10b5-1 | 6,394 | $45.17 | $288.8K | 163,408 −3.8% of holding | |
| Davis John E | Chief Commercial Officer | Sell 10b5-1 | 6,394 | $45.17 | $288.8K | 198,842 −3.1% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 6,000 | $45.73 | $274.4K | 135,380 −4.2% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell 10b5-1 | 6,393 | $45.00 | $287.7K | 163,408 −3.8% of holding | |
| Davis John E | Chief Commercial Officer | Sell 10b5-1 | 6,393 | $44.67 | $285.6K | 198,842 −3.1% of holding | |
| Mackin James P | President & CEO | Sell | 34,210 | $45.86 | $1.6M | 800,993 −4.1% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 6,563 | $45.86 | $301.0K | 198,842 −3.2% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 5,761 | $45.86 | $264.2K | 163,408 −3.4% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 4,993 | $45.86 | $229.0K | 56,641 −8.1% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 3,482 | $45.86 | $159.7K | 141,380 −2.4% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 10,000 | $46.18 | $461.8K | 169,169 −5.6% of holding | |
| Mackin James P | President & CEO | Sell | 17,580 | $44.62 | $784.4K | 835,203 −2.1% of holding | |
| Davis John E | Chief Commercial Officer | Sell | 3,373 | $44.62 | $150.5K | 205,405 −1.6% of holding | |
| Holloway Jean F | SVP, General Counsel | Sell | 2,960 | $44.62 | $132.1K | 169,169 −1.7% of holding | |
| Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2,566 | $44.62 | $114.5K | 61,634 −4% of holding | |
| Horton Amy | VP, Chief Accounting Officer | Sell | 1,789 | $44.62 | $79.8K | 144,862 −1.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.